Organization · Venture Capital
Vida Ventures, LLC
Vida Ventures, LLC is a life sciences investment firm based in the United States, focusing on transformative biomedical innovations. The firm manages approximately $1.8 billion in assets and has a bicoastal presence.
Overview
What Vida Ventures, LLC does
What Vida Ventures, LLC is
Vida Ventures, LLC is a life sciences investment firm based in the United States, focusing on transformative biomedical innovations. The firm manages approximately $1.8 billion in assets and has a bicoastal presence.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Vida Ventures, LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Vida Ventures, LLC as a funder
Investment thesis
Vida Ventures focuses on advancing transformative biomedical innovations in the life sciences sector, particularly therapeutics, leveraging a science-led and discipline-driven investment approach.
Focus narrative
Vida Ventures invests in the life sciences sector, specifically in therapeutics. The firm employs a flexible investment strategy that allows it to support companies at various stages of development across different therapeutic areas, informed by extensive experience in both early-stage startups and commercial-stage enterprises.
Value beyond capital
Vida Ventures adds value to its portfolio companies through its deep expertise in life sciences, providing strategic guidance and access to a network of industry leaders and resources. The firm's team, composed of experienced scientists and entrepreneurs, is well-equipped to support the growth and development of innovative therapeutics.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Halda Therapeutics and Capstan Therapeutics
Portfolio context
Notable portfolio companies include: A2 Biotherapeutics: Advanced biologics technology platform for next-generation immunotherapies. Aktis Oncology: Focused on discovering and developing targeted radiopharmaceuticals for solid tumor cancers. Allogene Therapeutics: Developing allogeneic CAR T therapies for cancer. Halda Therapeutics: Innovating a novel class of cancer therapies called RIPTACTM. Kyverna Therapeutics: Developing cell therapies for autoimmune diseases. Neogene Therapeutics: Personalized T cell therapies for cancer, acquired by AstraZeneca in 2023. Peloton Therapeutics: Advancing small molecule therapies, acquired by Merck in 2019.
Common questions
What to know about Vida Ventures, LLC
Upseed classifies Vida Ventures, LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.